Table 2.
The median volume (mm3) of 3D facial imaging analysis at baseline (T0), 4 (T1), 8 (T2), and 12 (T3) weeks after the botulinum toxin injection
| Area | Volume [mm3, median (q1-q3)] | p-value* | |||
|---|---|---|---|---|---|
| T0 | T1 | T2 | T3 | ||
| Left side |
235,364 (219,078–269,013) |
232,875 (214,548 − 263,442) |
231,732 (215,273 − 261,103) |
232,633 (213,779 − 263,688) |
0.002 |
| Right side |
238,900 (223,246–263,735) |
235,786 (218,858 − 257,902) |
232,110 (219,339 − 257,633) |
232,647 (219,831 − 257,853) |
< 0.001 |
| Both sides |
481,030 (442,907 − 529,899) |
470,490 (439,458–521,047) |
473,433 (434,174–514,191) |
467,572 (439,800 − 515,133) |
< 0.001 |
*Friedman’s statistical analysis and the significant level was taken at p < 0.05